Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Neuland Laboratories Ltd

NSE: NEULANDLAB · BSE: 524558 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹21,890.00
Market cap: ₹28,085 Cr
Revenue (annual): ₹2,023 Cr
Net profit (annual): ₹364.0 Cr
P/E (TTM): 56.4×Sector 50.4×
Promoter holding: 32.62%-0.01% QoQ
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Production Started 1 Capacity Expansion 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 16:03 IST NSE

Financial Results

Neuland Laboratories Q1 FY27 Results: Net Profit ₹147.7 Cr, Up 962.6% YoY

Neuland Laboratories Ltd reported revenue from operations of ₹641.6 Cr (+119.1% YoY) and net profit of ₹147.7 Cr (+962.6% YoY) for Q1 FY27.

Key figure: Net profit ₹147.7 Cr · +962.6% YoY

Open full results → Read the filing ↗

12 May 2026 16:12 IST BSE

Financial ResultsAlfa Alert

Neuland Laboratories Q4 FY26 Results: Net Profit ₹212.7 Cr, Up 665.1% YoY

Neuland Laboratories Ltd reported revenue from operations of ₹776.3 Cr (+136.4% YoY) and net profit of ₹212.7 Cr (+665.1% YoY) for Q4 FY26.

Key figure: Net profit ₹212.7 Cr · +665.1% YoY

Open full results → Read the filing ↗